@TOME V2.3
(Nov 2016)

Ref. - - Doc.
Global output mode :
Sort entries by :
Sequence Color type :

Show alignment :
Column output:
Score:

Alignment:

3D Common Core:

Structural Clustering:

Modeller Result :

Complexes Modeling
Templates Information:
Sequence & Result Tab:

Values color: [ Good | Correct | Middling | Bad ]Comparative Docking Tab: Displays ligands Score after transfer from template to model
Cell color: RMS between binding site of experimental template and receptor: [‹ 3Å | ‹ 10Å | › 10Å]
Result: [ Good | Correct | Acceptable | Bad | Empty = ligand not selected during the calculation step or result rejected ]

Query sequence : PF07686_VGFR2_HUMAN: (2014-10-12 )
MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV

Atome Classification :

(33 SA) Binding Score for complex ligand / Scwrl (Unconserved SChains Recalculated) model (Only selected ligand are displayed)
(Atome) (Ident) (Tito) (Num) (pKd) (Uniprot)

K11_A_2(3EWH)

[Raw transfer]




706_B_4(3EFL)

[Raw transfer]




BAX_A_2(4ASD)

[Raw transfer]




C19_B_4(3CP9)

[Raw transfer]




608_D_4(2P2I)

[Raw transfer]




608_C_3(2P2I)
VGFR2_HUMAN
[Raw transfer]




42Q_A_2(3VHE)

[Raw transfer]




0KF_A_2(3VO3)

[Raw transfer]




276_A_2(2QU5)

[Raw transfer]




8ST_A_2(3HNG)

[Raw transfer]




03X_A_2(3U6J)

[Raw transfer]




706_A_3(3EFL)
VGFR2_HUMAN
[Raw transfer]




C19_A_3(3CP9)
VGFR2_HUMAN
[Raw transfer]




2RL_A_2(2RL5)

[Raw transfer]




0JA_A_2(3VNT)

[Raw transfer]




887_B_5(3B8R)

[Raw transfer]




C92_B_4(3CPB)

[Raw transfer]




900_B_4(3B8Q)

[Raw transfer]




RAJ_A_2(3BE2)

[Raw transfer]




857_B_5(2QU6)

[Raw transfer]




994_B_2(2P2H)

[Raw transfer]




887_A_4(3B8R)
VGFR2_HUMAN
[Raw transfer]




C52_B_4(3CPC)

[Raw transfer]




AAX_B_2(1Y6B)

[Raw transfer]




AXI_A_2(4AG8)

[Raw transfer]




C92_A_3(3CPB)
VGFR2_HUMAN
[Raw transfer]




C52_A_3(3CPC)
VGFR2_HUMAN
[Raw transfer]




900_A_3(3B8Q)
VGFR2_HUMAN
[Raw transfer]




00J_A_2(2XIR)

[Raw transfer]




BPK_A_2(3VHK)

[Raw transfer]




AAZ_A_2(1Y6A)

[Raw transfer]




A96_A_3(3DTW)
VGFR2_HUMAN
[Raw transfer]




KIM_A_4(3CJG)

[Raw transfer]




EDO_A_3(3VHK)

[Raw transfer]




EDO_A_3(3VNT)

[Raw transfer]




6 PsiBlast_PDB 95.05100%-110 - C2 -3VHE 10.6
3 PsiBlast_PDB 94.1399%-105 - C2 -3VHK 7.0
5 PsiBlast_PDB 92.36100%-124 - C2 -1Y6B 8.5
4 PsiBlast_PDB 90.41100%-125 - C2 -1Y6A 6.7
39 PsiBlast_CBE 86.1173%-105 - C2 -3HNG 8.7
17 PsiBlast_PDB 85.1585%-112 - C2 -3EWH 11.1
16 PsiBlast_PDB 85.0785%-109 - C2 -3U6J 11.9
9 PsiBlast_PDB 85.0586%-108 - C2 -4ASD 9.7
11 PsiBlast_PDB 84.1686%-108 - C2 -3VNT 10.3
12 PsiBlast_PDB 84.1186%-111 - C2 -3VO3 9.5
13 PsiBlast_PDB 83.6686%-113 - C2 -2XIR 9.7
30 PsiBlast_CBE 83.5784%-114 - C2 -3BE2 11.4
35 PsiBlast_CBE 83.4884%-113 - C2 -2RL5 10.2
20 PsiBlast_PDB 83.4184%-118 - C2 -2P2H 7.2
14 PsiBlast_PDB 83.1486%-110 - C2 -4AG8 9.5
37 PsiBlast_CBE 83.0884%-116 - C2 -2QU5 10.3
32 PsiBlast_CBE 82.9584%-122 - C2 -3B8R 9.8 VGFR2_HUMAN
34 PsiBlast_CBE 82.6684%-117 - C2 -3B8Q 10.3 VGFR2_HUMAN
18 PsiBlast_PDB 82.6584%-117 - C2 -2P2I 9.6 VGFR2_HUMAN
29 PsiBlast_CBE 82.6284%-118 - C2 -3CP9 9.1 VGFR2_HUMAN
27 PsiBlast_CBE 82.5284%-123 - C2 -3CPB 7.6 VGFR2_HUMAN
19 PsiBlast_PDB 82.3084%-112 - C2 -3EFL 8.8 VGFR2_HUMAN
23 PsiBlast_CBE 82.2984%-113 - C2 -3DTW 8.5 VGFR2_HUMAN
25 PsiBlast_CBE 82.2684%-121 - C2 -3CPC 9.5 VGFR2_HUMAN
22 PsiBlast_CBE 80.6884%-128 - C2 -2P2I 9.0
31 PsiBlast_CBE 80.6184%-124 - C2 -3B8R 9.7
33 PsiBlast_CBE 80.1484%-119 - C2 -3B8Q 10.7
28 PsiBlast_CBE 79.7684%-121 - C2 -3CP9 9.0
36 PsiBlast_CBE 79.2984%-126 - C2 -2QU6 10.0
24 PsiBlast_CBE 78.7484%-123 - C2 -3CPC 9.6
21 PsiBlast_CBE 78.4184%-124 - C2 -3EFL 8.4
26 PsiBlast_CBE 77.6584%-122 - C2 -3CPB 8.1
38 PsiBlast_CBE 57.1783% -12 * C2 *3CJG 5.9